Global Retirement Partners LLC Makes New $4.34 Million Investment in Pfizer Inc. $PFE
Market Beat·- Global Retirement Partners LLC acquired a new position of 180,182 shares in Pfizer Inc. valued at approximately $4.34 million during the 2nd quarter. - Pfizer recently reported second-quarter earnings with an EPS of $0.77 and revenue of $15.03 billion, outperforming analyst estimates. - The company faces mixed market sentiment driven by institutional investments, high dividend yields, legal settlements, and challenges related to its upcoming patent cliff.3S Bio Announces 2026 Interim Results: Innovation-Driven, Win-Win Collaboration, and Sustainable Growth
PR Newswire·- 3SBio reported its 2026 interim results, posting a revenue of RMB 4.53 billion and an adjusted operating net profit of RMB 1.44 billion, representing a 26.5% year-over-year increase. - The company advanced its innovation pipeline by securing marketing approvals for three Class 1 innovative drugs, advancing five products to the New Drug Application stage, and driving global clinical trials for PF-08634404. - 3SBio also expanded its multi-therapeutic portfolio across oncology, autoimmune diseases, and nephrology, while its Wind ESG rating was upgraded to "AA" for its sustainable development practices.